Introduction {#sec1}
============

G-quadruplexes are formed in DNA and RNA sequences bearing repetitive G-tracts.^[@ref1],[@ref2]^ The quadruplex core consists of at least two stacked planar G-quartets which are stabilized by hydrogen bonds on their Watson--Crick and Hoogsteen faces and π--π interactions between the planes of the quartets ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a).^[@ref3],[@ref4]^ Cations, particularly potassium, are coordinated by the O^6^ oxygens of the guanines and contribute strongly to the overall stability of the structure.^[@ref5]^ G-quadruplexes can adopt antiparallel or parallel topologies that are determined by the connectivity of their loops.^[@ref6]^ RNA quadruplexes generally adopt parallel topologies because of the favored *anti* conformation of the nucleotide.^[@ref7]^

![Structure of human telomeric RNA (TERRA) quadruplex. (a) Guanine quartet (G-quartet) stabilized by a potassium cation (K^+^). (b) Bottom view of TERRA quadruplex (PDB accession: 3ibk) with 2′-hydroxyl groups of the 3′-terminal G-quartet colored in red. Conjugation of the fluorophores Cy3 (magenta) and Cy5 (blue) at positions in accordance with Q~A~-c53 and Q~A1~-c53 is modeled by the geometrical search algorithm FPS.^[@ref41]^ The accessible volumes (mesh) and mean positions (spheres) of the fluorophores are simulated. The distance between calculated mean fluorophore positions is 17.4 Å (dashed line), whereas the distance between the dyes' attachment points (the 2′-oxygen atoms) is 11.9 Å. Analysis visualized with PyMOL (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC). (c) Exposure of 2′-hydroxyl groups at the 3′-terminal G-quartet in a parallel RNA quadruplex with the guanosines numbered from 1 to 12 (from 5′ to 3′ end). (d) Side view of modeling in (b). Note that guanosines G3 and G12 are subjected to Cy5 and Cy3 conjugation, respectively.](ao-2019-00704s_0001){#fig1}

RNA G-quadruplexes play roles in many cellular processes. When present in mRNA untranslated regions (UTRs), they can alter rates of translation,^[@ref8]−[@ref11]^ splicing,^[@ref12],[@ref13]^ polyadenylation,^[@ref14],[@ref15]^ transcription,^[@ref16],[@ref17]^ mRNA localization,^[@ref18]^ and polyamine homeostasis.^[@ref19]^ In specific sequences, G-quadruplexes equilibrate with stem-loop structures. This can affect, for example, the expression of disease-related genes^[@ref19]−[@ref21]^ and the processing of precursor microRNAs (pre-miRNAs).^[@ref22]−[@ref24]^

Conventional biophysical techniques for the characterization of G-quadruplexes in vitro are UV melting at 295 nm, circular dichroism (CD) spectroscopy, and staining with Thioflavin-T after gel electrophoresis. However, these methods alone are insufficient to prove the existence of a quadruplex, and new techniques are needed to enable the study of their sometimes-complex equilibria and the kinetics of their folding. Förster resonance energy transfer (FRET) is a method to measure distances between donor and acceptor fluorophores in macromolecules or macromolecular complexes.^[@ref25]^ FRET is often used to study the dynamics of G-quadruplexes;^[@ref26]−[@ref29]^ typically, donor and acceptor fluorophores are conjugated to the 5′ and 3′ ends of an oligoribonucleotide comprising G-tracts of a putative quadruplex. The fluorophores are most easily introduced in the form of commercially available phosphoramidites or via coupling of activated esters to amino linkers after solid-phase synthesis. Folding of the sequence into a compact quadruplex, mediated by increased concentrations of cations, brings the acceptor and donor into proximity and allows FRET between them. Although the terminal labeling of oligoribonucleotides with fluorophores is relatively straightforward, it offers little flexibility in structural design and can even confound FRET data as dyes may stabilize or destabilize the nucleic acid under study.^[@ref27],[@ref30]−[@ref32]^ Site-specific (internal) labeling of structured RNAs is synthetically challenging but has provided important insights on RNA function.^[@ref33]^ Fluorophore labeling at internal positions of oligoribonucleotides offers much greater flexibility for an optimal distal positioning of the fluorophores; it allows the study of quadruplex folding and structural equilibrations in longer RNAs. An internal labeling of guanosines in G-quartets was described for DNA quadruplexes where modified nucleobases served as donor and acceptor groups.^[@ref34]^ However, these fluorescent 8-aryl dG probes force a *syn* conformation of the guanosines and an antiparallel arrangement that may not represent the natural structure of RNA quadruplexes.

There are three ways by which functionalities can be incorporated site-specifically into oligoribonucleotides, depending on the chemical stability and reactivity of the conjugate: (i) use of modified phosphoramidites during solid-phase synthesis, (ii) post-synthetic addition on a solid support using classical biocompatible reactions, and (iii) solution-phase conjugations after oligonucleotide synthesis/deprotection and purification. Where it is required to incorporate two distinct groups (i.e., donor and acceptor fluorophores) into one sequence without cross-reaction at reactive sites, a combination of these methods can be employed.^[@ref35]^ For instance, to incorporate a psoralen cross-linker and a biotin handle into pre-miRNAs, we used a combination of (i) and (ii).^[@ref36]^ To label miRNAs with Cy3 and a black hole quencher, we used a variant of method (ii) with two click reactions and an interruption of the solid-phase protocol.^[@ref37]^ The instability of Cy5 groups to the harsh conditions of oligonucleotide deprotection means that it is best coupled in solution, for example, employing a "click-reverse-click" protocol which we recently developed.^[@ref38]^

The analysis of a crystal structure of a canonical RNA G-quadruplex indicated that an optimal FRET labeling of guanosines involved in a quadruplex could be achieved via their 2′-hydroxyl groups ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b--d). Importantly, this labeling strategy does not disturb the *anti* conformation of the guanosine, thus rendering it compatible with the formation of a canonical parallel RNA G-quadruplex. Here, we describe a combination of solid- and solution-phase synthesis to conjugate site-specifically Cy3 and Cy5 fluorophores to selected guanosines of proximal G-tracts using copper-catalyzed azide-alkyne cycloaddition ("click chemistry"). To the best of our knowledge, this work represents the first internal labeling strategy to study RNA G-quadruplexes using FRET measurements from participating guanosines.

Results and Discussion {#sec2}
======================

As RNA G-quadruplexes predominantly form with parallel topology, we reasoned that structural insights from the crystal structure of the human telomeric RNA (TERRA) quadruplex^[@ref7]^ might extend to quadruplexes formed from different RNAs. We therefore analyzed the structure of TERRA for potential sites for fluorophore labeling, that is, that are outward facing, which are in close proximity when folded but are separated in differently folded or unfolded structures. Indeed, the 2′-hydroxyl groups of the guanosines G~3~ and G~12~ in proximal G3 tracts at the 3′-terminal G-quartet of the quadruplex fulfilled these requirements ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b--d). We chose a medium linker length (∼12 Å) that is close to the recommended length (∼14 Å) for cyanine dyes internally attached to RNA duplexes.^[@ref39]^ To reduce possible RNA--fluorophore interactions, we used sulfonated variants of the cyanine dyes Cy3 and Cy5.^[@ref40]^ Using the geometrical search algorithm FPS,^[@ref41]^ we modeled Cy3/Cy5 bis-labeling at these guanosines in a quadruplex, taking into account the dimensions of the dyes and the linker ([Figures S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00704/suppl_file/ao9b00704_si_001.pdf) and [1](#fig1){ref-type="fig"}b,d). This gave a calculated distance of 17.4 Å between the mean fluorophore positions and a calculated FRET efficiency *E* = 99.9% assuming a Förster radius *R*~0~ ≈ 60 Å for the Cy3/Cy5 FRET pair.^[@ref42]^ The estimated distance between the mean fluorophore positions in our internally labeled RNA structures (∼17 Å) is less than that typically used for single-molecule FRET (*R* ≈ 0.58 *R*~0~) to distinguish highly polymorphic G-quadruplexes (e.g., telomeric DNA G-quadruplexes).^[@ref28]^ We then selected two well-characterized G-quadruplexes HpG4-2^[@ref43],[@ref44]^ and HpQd^[@ref45]^ (hereafter designated Q~A~ and Q~B~, respectively). Both have been found to equilibrate with alternative hairpin structures.

We expanded the number of sequences in the investigation by exchanging three nucleotides in Q~A~ and Q~B~ to give Q~A1~ and Q~B1~, respectively ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a,b). These exchanges prevented the Watson--Crick base pairing needed for equilibration to hairpins in Q~A~ and Q~B~ ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00704/suppl_file/ao9b00704_si_001.pdf)) and constrained the conformations of Q~A1~ and Q~B1~ to quadruplexes.

![Structure and properties of G-quadruplexes Q~A~, Q~B~, and variants. (a) Representation of the G-quadruplex formation of Q~A~.^[@ref43]^ Indicated changes at the NNN site give Q~A1~. Sites of internal labeling are marked with asterisks (Cy3\*, Cy5\*\*). (b) Representation of the G-quadruplex formation of Q~B~.^[@ref45]^ Indicated changes at the NNN site give Q~B1~. Sites of internal labeling are marked with asterisks (Cy3\*, Cy5\*\*). (c) Representative UV-melting curves at 295 nm in the presence of 1 mM KCl and the calculated *T*~m~'s of Q~A~ and Q~A1~. (d) Representative UV-melting curves at 295 nm in 20 mM KCl and the calculated *T*~m~'s of Q~B~ and Q~B1~.](ao-2019-00704s_0002){#fig2}

An invariable property of RNA quadruplexes is a hypochromic shift at 295 nm upon thermal melting. Indeed, Q~A1~ and Q~B1~ yielded *T*~m~'s of 67 and 78 °C, respectively, with small increases in *T*~m~ compared to those of Q~A~ and Q~B~ ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c,d). Q~A1~ and Q~B1~ showed no melting at 260 nm (data not shown). The modeling studies pointed to the 2′-hydroxyl groups of G~3~ and G~12~ as optimal sites for fluorophore conjugations, respectively.

A synthesis strategy to these target molecules is needed to circumvent two potential issues: cross-labeling in which incomplete conjugation reactions lead to inseparable mixtures of fluorophore modifications and the instability of Cy5 to conditions of oligonucleotide deprotection. The high G-content of the sequences is added to the challenge of synthesizing these RNAs. We decided to employ two copper-catalyzed azide-alkyne cycloaddition ("click chemistry") reactions, the first with a ("stop-go") conjugation of Cy3 during interrupted solid-phase synthesis and the second with a solution-phase addition of Cy5.^[@ref35]^

In the stop-go process, solid-phase couplings were carried out with standard phosphoramidites and the first 2′-*O*-propargyl-bearing guanosine phosphoramidite (**1**, see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00704/suppl_file/ao9b00704_si_001.pdf)), until the penultimate site for the second modification in the sequence was reached ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a). The controlled-pore glass (CPG) support was then removed from the synthesizer and used for the reaction with Cy3-azide (**2**).^[@ref37]^ After the reaction, CPG was washed liberally with acetonitrile (ACN) and dried overnight. Automated synthesis was then resumed with coupling of the second modified guanosine. Upon completion of machine synthesis, CPG was treated with ammonia/methylamine and fluoride solutions under standard conditions. High-performance liquid chromatography (HPLC) purification in the DMT-on mode removed truncated sequences and yielded pure Cy3-modified oligoribonucleotides. After DMT cleavage, the second click reaction with (**3**) was performed as described previously.^[@ref38]^ The highly lipophilic Cy5 group facilitates the second HPLC purification in which mono-labeled starting material was separated from the desired bis-conjugated products. The mass and purity of the bis-labeled oligoribonucleotides were verified by liquid chromatography--mass spectrometry (LC--MS) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}; [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b). Following this approach, a small library of Cy3- and/or Cy5-labeled analogues of Q~A~ and Q~B~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) was produced for FRET-based assays. Mono-labeled oligoribonucleotides Cy3 and Cy5 analogues were prepared as controls using the standard click reactions on the CPG and in solution, respectively, according to our published protocols.^[@ref37],[@ref38]^

![Preparation of Cy3- and Cy5-bis-labeled oligoribonucleotides. (a) Copper-catalyzed azide-alkyne cycloaddition reaction on the CPG (click 1) and in solution (click 2) was used to introduce internal labels: Cy3 and Cy5, respectively. (b) LC--MS chromatograms of bis-labeled oligoribonucleotides: Q~A1~-c53 (left) and Q~B1~-c53 (right).](ao-2019-00704s_0003){#fig3}

###### Synthesized Oligoribonucleotides[a](#t1fn1){ref-type="table-fn"}

  ORN      RNA         sequence (5′ to 3′)                         mass calc.   mass found
  -------- ----------- ------------------------------------------- ------------ ------------
  **1**    Q~A~        AGCCGGGCUGGGGCUGGGCGGGGA                    7912.8       7913.0
  **2**    Q~A~-c5     AGCCGG[X]{.ul}CUGGGGCUGGGCGGGGA             8538.7       8539.2
  **3**    Q~A~-c3     AGCCGGGCUGGGGCUGGGCGGG[Y]{.ul}A             8512.6       8511.8
  **4**    Q~A~-c53    AGCCGG[X]{.ul}CUGGGGCUGGGCGGG[Y]{.ul}A      9138.5       9136.9
  **5**    Q~A1~       AAAAGGGCUGGGGCUGGGCGGGGA                    7944.9       7943.7
  **6**    Q~A1~-c3    AAAAGGGCUGGGGCUGGGCGGG[Y]{.ul}A             8544.7       8543.6
  **7**    Q~A1~-c53   AAAAGG[X]{.ul}CUGGGGCUGGGCGGG[Y]{.ul}A      9170.6       9169.2
  **8**    Q~B~        AGGGAGGGGCGGGAGUGGGCUACCCGC                 8876.5       8874.9
  **9**    Q~B~-c5     A[X]{.ul}GGAGGGGCGGGAGUGGGCUACCCGC          9502.4       9538.3
  **10**   Q~B~-c3     AGGGAGGGGCGGGAGU[Y]{.ul}GGCUACCCGC          9476.3       9475.1
  **11**   Q~B~-c53    A[X]{.ul}GGAGGGGCGGGAGU[Y]{.ul}GGCUACCCGC   10 102.2     10 100.6
  **12**   Q~B1~       AGGGAGGGGCGGGAGUGGGCUAAAAGC                 8948.5       8947.2
  **13**   Q~B1~-c3    AGGGAGGGGCGGGAGU[Y]{.ul}GGCUAAAAGC          9548.3       9547.3
  **14**   Q~B1~-c53   A[X]{.ul}GGAGGGGCGGGAGU[Y]{.ul}GGCUAAAAGC   10 174.2     10 174.1
  **15**   Q~A2~       AAAAGGGCUGGGGCUAAACGGGGA                    7896.9       7895.9

X, Y: G modified with Cy5 and Cy3, respectively (see [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} for the structures).

CD spectra of Q~A~ and Q~A1~ and their bis-labeled variants Q~A~-c53 and Q~A1~-c53 were recorded to examine potential effects of the fluorophores on the native fold of these RNA G-quadruplexes. The CD profiles of all four sequences were consistent with a parallel G-quadruplex structure characterized by a peak at ∼264 nm and a trough at ∼240 nm.^[@ref46]^ The unfolded negative control Q~A2~, a variant of Q~A1~ where the third G-tract was mutated to adenosines to prevent any G-quadruplex formation, showed a shift toward a higher wavelength (∼267 nm) and an additional trough ∼207 nm consistent with the absence of a G-quadruplex structure ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a).^[@ref19],[@ref46],[@ref47]^ Canonical RNA G-quadruplexes show a preference for binding potassium cations.^[@ref5]^ Hence, we measured the emission spectra after excitation (515 nm) of Q~A~-c53 in the presence or absence of 100 mM KCl ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b). The emission spectra are normalized to the maximum of the donor peaks (∼567 nm), thus the magnitude of the acceptor peak (∼675 nm) reflects a measure of FRET, as reported by Maleki et al.^[@ref28]^ We obtained a potassium-dependent increase in FRET indicated by an increased acceptor peak (∼675 nm) consistent with the quadruplex-promoting effect of K^+^.

![FRET studies of labeled G-quadruplexes of [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. (a) CD spectra of Q~A~ (blue), Q~A~-c53 (red), Q~A1~ (green), Q~A1~-c53 (purple), and Q~A2~ (orange). Vertical line (gray) at 267 nm indicates the characteristic peak maximum of the unfolded, non-quadruplex negative control Q~A2~ (orange). Note the shift of the quadruplex specific peaks to the left (∼264 nm). (b) Emission spectra of Q~A~-c53 after excitation at 515 nm in the absence (blue) or presence (red) of 100 mM KCl. (c) Emission spectra of Q~A~-c53 after excitation at 515 nm treated (red) or not treated (blue) with RNase T1. (d) Emission spectra of Q~A~-c53 after excitation at 515 nm before (blue) and 1 h after the addition of tRNA (red). (e) Emission spectra of Q~A1~-c53 after excitation at 515 nm in the presence of different KCl concentrations. (f) Relative FRET efficiencies of KCl concentration series (d) are shown as bar graphs (+SD, *n* ≥ 3). (g) Emission spectra of Q~B~-c53 after excitation at 515 nm in the absence (blue) or presence (red) of 100 mM KCl. (h) Emission spectra of Q~B1~-c53 after excitation at 515 nm in the absence (blue) or presence (red) of 100 mM KCl. Emission spectra of the K^+^-dependent studies (b,e,g,h) are normalized to the maximum of the donor peaks at 567 nm according to the FRET representation of Maleki et al.^[@ref28]^](ao-2019-00704s_0004){#fig4}

To add further support that the FRET signal of Q~A~-c53 is derived from its quadruplex conformation, we performed two treatments on Q~A~. Nucleases are expected to disrupt RNA G-quadruplexes^[@ref1]^ and are frequently used in RNA footprinting experiments.^[@ref48]^ Indeed, addition of RNase T1 to Q~A~-c53 caused an approximate threefold decrease in *E*~rel~, displayed by a loss of the acceptor peak (∼675 nm) and an increase of the donor peak (∼567 nm), consistent with loss of FRET and disruption of the structure ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}c). It was previously reported that the presence of ^t^RNAs shifted the G-quadruplex-hairpin equilibrium of Q~A~ toward a hairpin conformer.^[@ref43]^ The authors postulated that this was due to a C-tract in the exposed anticodon forming Watson--Crick bonds to the G-tracts in Q~A~. Therefore, we also performed FRET measurements on Q~A~-c53 before and after addition of bacterial ^t^RNA ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}d). Indeed, added ^t^RNA caused an approximate 20% decrease in E~rel~, indicated by a decrease of the acceptor peak (∼675 nm) and a small increase of the donor peak (∼567 nm), in line with the earlier published account.^[@ref43]^ Additionally, we tested the quadruplex Q~A1~-c53 for its response to potassium over a range from 0 to 1000 mM KCl. As expected, quadruplex Q~A1~-c53 showed similar behavior to that of Q~A~-c53 with a quadruplex-promoting effect of K^+^ ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b,e,f). During these measurements, we noted a relatively strong quenching of the donor but a comparatively low sensitization of the acceptor ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00704/suppl_file/ao9b00704_si_001.pdf)a). This was attributed to a loss of acceptor efficiency in the G-quadruplex state ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00704/suppl_file/ao9b00704_si_001.pdf)b) due possibly to quenching effects, for example, fluorescence quenching of the G-quartet, dye-dye contact quenching, or possibly effects from K^+^.^[@ref49]−[@ref51]^

To demonstrate that this new approach of labeling/detecting participating guanosines in RNA G-quadruplexes is applicable to other sequences, we conducted FRET experiments on the second pair of structures, Q~B~ and Q~B1~. This time, we investigated labels introduced at the guanosines of the 5′-terminal quartet ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b). To this end, we measured the emission spectra after excitation (515 nm) of Q~B~-c53 and Q~B1~-c53 in the presence or absence of 100 mM KCl ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}g,h). Both sequences showed the G-quadruplex-promoting effect of KCl through an increase of the acceptor peak (∼675 nm). Of note, we observed an increase in *E*~rel~ of ∼0.1 for the second pair of structures Q~B~-c53/Q~B1~-c53 compared to Q~A~-c53/Q~A1~-c53 in both 0 and 100 mM KCl ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b,e,g,h). This can be attributed to sequence-specific structural differences and/or the different positioning of the fluorophores ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a,b).

To confirm that the emission peak at ∼ 675 nm of Q~A~, Q~B~, and their variants indeed originated from acceptor (Cy5) emission, we measured the emission spectra after excitation at 515 nm of the mono-labeled (Cy3) sequences Q~A~-c3, Q~A1~-c3, Q~B~-c3, and Q~B1~-c3 ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00704/suppl_file/ao9b00704_si_001.pdf)). For all sequences, the peak at ∼675 nm was absent, and the spectral bleed-through of donor emission into the region of expected Cy5 emission (∼675 nm) was relatively low.

In summary, we describe here a novel FRET-based strategy to detect RNA G-quadruplexes, which differs from current methods^[@ref26]−[@ref29]^ by internal site-specific fluorophore labeling of participating guanosines. Our synthetic strategy employed two click reactions, with interruption of the solid-phase synthesis to avoid cross-reactions. We exemplified our method on a series of sequences under different assay conditions. We expect this method to find applications in the rapidly expanding field of RNA G-quadruplexes, for example, in the study of noncanonical quadruplexes or for structural equilibria involving quadruplex folding. In contrast to terminal labeling strategies, our method is not limited to short oligoribonucleotides and would also allow the study of G-quadruplex formation in long functional RNAs, possibly in cellular media. The results of these studies will be reported in due course.

Experimental Procedures {#sec3}
=======================

Chemical Synthesis of the Reagents {#sec3.1}
----------------------------------

Thin-layer chromatography was done on silica gel 60 Å F254 aluminum plates (Merck). Preparative column chromatography was carried out on silica gel, 60 Å (Fluka). Chemical shifts are given in parts per million (ppm), *J* values are given in hertz (Hz), and NMR spectra were referenced to the residual undeuterated signals.

Cy3-azide **2** and Cy5-azide **3** were synthesized according to the published procedure.^[@ref37],[@ref38],[@ref52]^

Synthesis of the 2′-*O*-Propargyl Guanosine Phosphoramidite **1** (See the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00704/suppl_file/ao9b00704_si_001.pdf)) {#sec3.2}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### 2′-*O*-Propargyl-2-aminoadenosine **5** {#sec3.2.1}

The synthesis of **5** was performed with small changes according to the published procedure.^[@ref53]^

2-Aminoadenosine **4** (10.0 g, 35.5 mmol, 1.0 equiv) was dissolved in dimethylformamide (150 mL) at 100 °C. The mixture was cooled down to 0 °C, and sodium hydride (60% in mineral oil; 1.4 g, 35.5 mmol, 1.0 equiv) was added slowly. After 1 h, tetrabutylammonium iodide (2.6 g, 7.1 mmol, 0.2 equiv) and propargyl bromide (80% in toluene; 4.4 mL, 39.1 mmol, 1.1 equiv) were added slowly at room temperature. The reaction mixture was stirred overnight at room temperature. An additional amount of propargyl bromide (80% in toluene; 2.0 mL, 17.8 mmol, 0.5 equiv) and sodium hydride (60% in mineral oil; 1.14 g, 28.4 mmol, 0.8 equiv) was added, and the reaction mixture was stirred for additional 2 h. Then, the reaction mixture was concentrated. The residue was purified by flash column chromatography with a gradient 1--8% of MeOH in CH~2~Cl~2~ to give a mixture of 2′-*O*-propargyl-2-aminoadenosine **5** and 3′-*O*-propargyl-2-aminoadenosine as a yellow foam.

The mixture of the two isomers was separated by recrystallization from EtOH. The 3′-isomer remained in the solution, and the desired 2′-isomer was precipitated. After filtration, the precipitate was dried to give 2′-*O*-propargyl-2-aminoadenosine **5** as a yellow foam (7.0 g, 62%). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ \[ppm\] 7.94 (s, 1H), 6.78 (s, 2H), 5.85 (d, *J* = 6.8 Hz, 1H), 5.75 (s, 2H), 5.48 (t, *J* = 5.6 Hz, 1H), 5.28 (d, *J* = 5.2 Hz, 1H), 4.54 (t, *J* = 5.8 Hz, 1H), 4.32--4.15 (m, 3H), 3.94 (d, *J* = 3.0 Hz, 1H), 3.65--3.60 (m, 1H), 3.57--3.50 (m, 1H), 3.48--3.40 (m, 1H).

### 2′-*O*-Propargyl-2-methoxyacetamide Adenosine **6** {#sec3.2.2}

The synthesis of **6** was performed according to the published procedure.^[@ref54],[@ref55]^ Compound **6** was then converted to the dimethoxytrityl-protected guanosine **7**, following the published protocols.^[@ref37],[@ref56]^

### 2′-*O*-Propargyl-5′-dimethoxytrityl-2-methoxyacetamide Guanosine Phosphoramidite **1** {#sec3.2.3}

Starting material **7** (1.1 g, 1.6 mmol, 1.0 equiv) was co-evaporated with tetrahydrofuran (THF) (×2) and then dissolved in the same solvent (16.0 mL). Triethylamine (Et~3~N) (1.1 mL, 8.1 mmol, 5.0 equiv) and 2-cyanoethyl-*N*,*N*-diisopropylchlorophosphoramidite (0.54 mL, 2.4 mmol, 1.5 equiv) were then added. The reaction mixture was stirred at room temperature. After 1.5 h, another 1.5 equiv of 2-cyanoethyl-*N*,*N*-diisopropylchlorophosphoramidite was added. After 2 h, the reaction was complete. THF was evaporated, and the residue was dissolved in EtOAc. The organic layer was washed with 5% NaHCO~3~, brine, dried over the sodium sulfate, and evaporated. The crude was purified by flash column chromatography with a gradient 0--1% of MeOH in CH~2~Cl~2~ with 2% of Et~3~N to give compound **1** as a yellow foam (0.58 g, 40%). ^1^H NMR (400 MHz, acetonitrile-*d*~3~): δ \[ppm\] 7.89 (d, *J* = 9.1 Hz, 1H), 7.44 (t, *J* = 7.6 Hz, 2H), 7.36--7.19 (m, 7H), 6.83 (ddd, *J* = 9.0, 7.0, 5.4 Hz, 4H), 5.98--5.91 (m, 1H), 4.83 (td, *J* = 5.4, 3.2 Hz, 1H), 4.61--4.49 (m, 1H), 4.39--4.22 (m, 3H), 4.08--4.03 (m, 2H), 3.94--3.78 (m, 1H), 3.75 (dd, *J* = 3.1, 0.9 Hz, 6H), 3.73--3.56 (m, 4H), 3.40 (d, *J* = 2.7 Hz, 3H), 3.39--3.28 (m, 2H), 2.67 (dt, *J* = 6.0, 2.5 Hz, 2H), 2.48 (t, *J* = 6.0 Hz, 1H), 1.21--1.13 (m, 10H), 1.05 (d, *J* = 6.8 Hz, 2H). ^13^C NMR (101 MHz, acetonitrile-*d*~3~): δ \[ppm\] 159.3, 155.8, 138.6, 138.4, 136.3, 136.3, 130.7, 130.7, 128.6, 128.6, 128.5, 127.5, 117.9, 113.7, 87.2, 86.9, 84.7, 79.7, 76.3, 71.5, 59.5, 55.5, 43.8, 43.7, 43.6, 24.7, 24.6, 24.5, 24.4, 20.6, 1.5, 1.3. ^31^P NMR (162 MHz, acetonitrile-*d*~3~): δ \[ppm\] 150.04, 149.97. ESI--MS: positive mode (\[M + K^+^\]). Mass calcd, 934.3301; mass found, 934.3313.

Oligonucleotide Synthesis, Deprotection, and Purification {#sec3.3}
---------------------------------------------------------

Chemicals were purchased from Biosolve and Aldrich. Phosphoramidites were purchased from Thermo Fisher. The activator 5-benzylthio-1*H*-tetrazole was purchased from Carbosynth. All oligonucleotides used in this work were synthesized on a 50 nmol scale with the MM12 synthesizer (Bio Automation Inc.) using 500 Å UnyLinker CPG (ChemGenes).

The coupling time for 2′-*O*-TBDMS phosphoramidites was 2 × 150 s and that for the 2′-*O*-propargyl guanosine phosphoramidite was 2 × 240 s.

For deprotection, CPG was treated with gaseous methylamine for 1.5 h at 70 °C (unmodified oligoribonucleotides) or with a mixture of 200 μL of ammonia (25% in H~2~O) and 200 μL of methylamine (40% in H~2~O) for 6 h at 35 °C (modified oligoribonucleotides). After basic deprotection and cleavage from the solid support, CPG was washed with 3 × 200 μL of H~2~O/EtOH (1:1) mixture. To the solution, 20 μL of 1 N Tris-base was added, and it was evaporated to dryness in a SpeedVac. Desilylation was carried out by treatment with 130 μL of a mixture of *N*-methyl-2-pyrrolidone (60 μL), triethylamine (30 μL), and triethylamine trihydrofluoride (40 μL) at 70 °C for 2 h. The reaction was quenched by adding trimethylethoxysilane (200 μL, 3 min, room temperature). Diethyl ether was added (200 μL, 5 min, room temperature), and the mixture was vortexed and centrifuged.

The precipitate was dissolved in 200 μL of H~2~O and purified on an Agilent 1200 series preparative RP-HPLC on an XBridge OST C-18 column (10 × 50 mm, 2.5 μm; Waters) at 65 °C with a flow rate 5 mL/min. Buffer A: 0.1 M aqueous triethylamine/acetic acid, pH 8.0; buffer B: 100% MeOH; gradient 20--60% B in 5 min.

Fractions containing the DMT-on product were collected, dried in a SpeedVac, and treated with 40% aqueous acetic acid for 15 min at room temperature. Samples were concentrated in a SpeedVac, dissolved in 200 μL of H~2~O, and purified in the DMT-off mode by RP-HPLC on an XBridge OST C-18 column (10 × 50 mm, 2.5 μm; Waters) at 65 °C with a flow rate 5 mL/min. Buffer A: 0.1 M aqueous triethylamine/acetic acid, pH 8.0; buffer B~1~: 100% MeOH; buffer B~2~: 100% ACN; gradient 5--30% B~1~ in 5 min (Q~A~, Q~A~-c3, Q~A1~, Q~A1~-c3, Q~B~, Q~B1~), 5--40% B~1~ in 5 min (Q~B~-c5, Q~B~-c3, Q~B1~-c3), 5--50% B~1~ in 7 min (Q~A~-c5, Q~A~-c53, Q~A1~-c53, Q~B~-c53, Q~B1~-c53), or 2--20% B~2~ in 3 min (Q~A2~).

Fractions containing the desired product were collected and dried in a SpeedVac, and oligonucleotides were analyzed by the LC--MS (Agilent 1200/6130 system) on an Acquity OST C-18 column (2.1 × 50 mm; Waters). The column oven was set to 65 °C, flow-rate: 0.3 mL/min. Solvent C: H~2~O containing 0.4 M hexafluoroisopropanol, 15 mM triethylamine; solvent B: MeOH; gradient 5--35% B in 14 min (Q~B~, Q~B1~, Q~B~-c3), 5--40% B in 14 min (Q~B~-c5, Q~A~, Q~A1~), 5--45% B in 14 min (Q~A~-c5, Q~A~-c3, Q~B1~-c3, Q~A1~-c3), 5--30% B in 11 min (Q~A2~) or 5--50% B in 14 min (Q~A~-c53, Q~A1~-c53, Q~B~-c53, Q~B1~-c53).

UV absorption of the final products was measured in duplicate or triplicate on a NanoDrop 2000 spectrophotometer (Fisher Scientific). Concentrations were calculated based on the nearest-neighbor model with in-house programmed software.

Synthesis of Cy3- and/or Cy5-Labeled Oligoribonucleotides {#sec3.4}
---------------------------------------------------------

The Cy3 and Cy5 mono-labeled oligoribonucleotides were prepared by the post-synthetic copper-catalyzed azide-alkyne cycloaddition reaction between alkyne-bearing oligoribonucleotide and Cy3-azide **2** or Cy5-azide **3** performed on the solid support (before the first deprotection step) or in solution (on fully deprotected oligoribonucleotides), respectively, following the published protocols.^[@ref37],[@ref38]^

Synthesis of Bis-Labeled Oligoribonucleotides {#sec3.5}
---------------------------------------------

After the incorporation of the first propargyl-bearing guanosine (Y; [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), the synthesis was continued until the penultimate site for the second modification was reached. Subsequently, the first click reaction between the alkyne-modified oligoribonucleotide and Cy3 azide **2** was performed, as described before.^[@ref37],[@ref38]^ After the post-click washing, CPG was washed additionally with 5 mL of dry ACN, transferred back to the column, and dried overnight. Then, the synthesis was resumed starting from the coupling of the second 2′-*O*-propargyl-modified guanosine (position X in the sequences; [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Upon completion of the automated solid-phase synthesis, oligoribonucleotides were cleaved from the solid support and deprotected with aqueous ammonia/methylamine solution, followed by standard desilylation protocol. After HPLC purification in the DMT-on mode and removal of the DMT group, the click reaction in solution with Cy5 azide **3** was performed as described,^[@ref52]^ followed by the HPLC purification in the DMT-off mode.

Fluorescence Spectroscopy {#sec3.6}
-------------------------

Oligoribonucleotides were prepared at a concentration of 0.5 μM in a buffer containing 50 mM 2-(*N*-morpholino)ethanesulfonic acid--LiOH, 2 mM MgCl~2~, 0.05% Tween-20 adjusted to pH 7.0. KCl was added at the indicated final concentration. After incubation for 5 min at 95 °C, samples were progressively cooled down to 4 °C for 90 min and measured at room temperature in 384-well microplates (Corning; low volume, flat bottom, black polystyrene). Emission spectra were recorded from 530 to 775 nm (increments: 1 nm) with excitation at 515 nm in a microplate reader (Tecan Spark 20M). The relative FRET efficiency (*E*~rel~) was calculated after buffer subtraction and smoothing (Savitzky--Golay, convolution width 25) according to [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}. For the representation of FRET, the emission spectra at different concentrations of KCl were normalized to the maximum of the donor peaks (∼567 nm), as reported by Maleki et al.^[@ref28]^ To determine the relative acceptor efficiency (rel. AE), fluorescence emission at 675 nm was collected with excitation at 640 nm and normalized to a comparative sample (0 mM KCl; [Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00704/suppl_file/ao9b00704_si_001.pdf)b). The emission/excitation bandwidth was set to 5 nm.

^t^RNA from *Escherichia coli* MRE 600 (Merck, TRNAMRE-RO) was added to a final concentration of 20 μM, and the emission spectra were recorded after 1 h of incubation at room temperature.

For the enzymatic digestion, the sample was incubated for 1 h at 37 °C with 20 U/μL RNase T1 (Thermo Fisher Scientific, EN0541).

UV Melting {#sec3.7}
----------

Thermal melting was performed using a Varian Cary 300 spectrophotometer. Oligoribonucleotides at a concentration of 4 μM were prepared in 10 mM lithium cacodylate, pH 7.2 at the indicated concentration of KCl. The samples were heated for 5 min at 90 °C, then cooled down to 20 °C, and heated again to 90 °C (0.2 °C min^--1^). The absorbance at a wavelength of 295 nm was recorded every 0.2 °C, and the melting temperature (*T*~m~) was calculated as described previously.^[@ref19]^ Representative melting curves are shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c,d. The mean *T*~m~ of ≥2 scans is given.

CD Spectroscopy {#sec3.8}
---------------

CD spectra were recorded between 200 and 320 nm at 20 °C on a Jasco J-10 spectropolarimeter. The buffer subtracted average of more than three consecutive CD scans (20 nm min^--1^, 4 s response time, 0.5 nm data pitch, 2 nm bandwidth, light path 1 mm) is given. The RNAs were prepared at a concentration between 0.5 and 4.0 μM in 10 mM lithium cacodylate, 10 mM KCl, pH 7.2, heated for 5 min at 95 °C, and then progressively cooled down to room temperature for 60 min before to be equilibrated at 4 °C for \>1 h. The data were smoothed using a Savitzky--Golay filter (convolution width 25).

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b00704](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b00704).Dimensions of cyanine dye--linker combinations and selected emission spectra; structures of the compounds; NMR spectra; and LC--MS chromatograms of oligoribonucleotides used in this study ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00704/suppl_file/ao9b00704_si_001.pdf))
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